<DOC>
	<DOCNO>NCT03021265</DOCNO>
	<brief_summary>Study evaluate real-world safety , effectiveness appropriate use Micatrio® Combination Tablets treatment patient hypertension</brief_summary>
	<brief_title>To Evaluate Real-world Safety , Effectiveness Appropriate Use Micatrio® Combination Tablets Treatment Patients With Hypertension</brief_title>
	<detailed_description>Non-interventional study base newly collect data . The study consist baseline visit follow-up visit Week 4 , 8 , 12 , 24 , 36 52 patient newly initiate Micatrio® Combination Tablets . The patient follow discontinuation Micatrio® Combination Tablets treatment end study . All patient administrate Micatrio® Combination Tablets launch site contract sponsor register .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<criteria>Inclusion criterion : Patients prescribe Micatrio® Combination Tablets discretion investigator base Japanese package insert Patients never treat Micatrio® Combination Tablets enrolment Exclusion criterion : Patients participating/planned participate clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>